title: Variant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines.
abstract: BACKGROUND
  Recepteur d'origine nantais (RON) is a receptor tyrosine kinase whose overexpression has been observed in human gastric cancers. This study aimed to determine whether overexpression of the variant RONΔ160 could induce tumorigenicity of gastric cancer cells in vitro or in vivo, and whether its specific small molecule inhibitor (Compound I) could inhibit the effect of RONΔ160.
  
  
  METHODS
  We constructed human gastric cancer cell line MGC-803 that was stably transfected with a recombinant plasmid expressing RONΔ160, and the effect of RONΔ160 overexpression and macrophage-stimulating protein (MSP) activation on proliferation, migration and invasion abilities of MGC-803 cells were evaluated. Tumor-bearing mice with gastric cancer cells were used to analyze the effects of RONΔ160 overexpression and Compound I on implanted tumor growth.
  
  
  RESULTS
  In vitro, overexpression of RONΔ160 in MGC-803 cells resulted changes to their cell morphology, and promoted cell proliferation, migration and invasion. In addition, overexpression of RONΔ160 increased the proportion of cells in the S phase. The effect of RONΔ160 was significantly enhanced by induction of MSP inducing (p < 0.05). In vivo, RONΔ160 promoted the growth of MGC-803 cells in nude mice, including increased tumor size and weight, and lower tumor incubation period. The Compound I inhibited the tumorigenic abilities of RONΔ160 (p <0.05).
  
  
  CONCLUSIONS
  The results indicate that overexpression of the variant RONΔ160 altered the phenotype and tumorigenicity of MGC-803 cells. Its specific small molecule inhibitor could inhibit the effect of RONΔ160. Therefore, the variant RONΔ160 may become a potential therapeutic target for gastric cancer.
authors: Department of Oncology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003 China.
authors: Dong-Hui
authors: DH
authors: Zhou
authors: Department of Oncology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003 China.
authors: Chao
authors: C
authors: Li
authors: Department of Oncology, Dongnan Affiliated Hospital of Xiamen University, Zhangzhou, China.
authors: Li-Na
authors: LN
authors: Yang
keywords: Gastric cancer; MSP; RON; RONΔ160; Tumorigenicity